Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Detlev Riesner, Werner Brandt, Elaine Mardis, Steve Allen, and More


Qiagen Co-Founder Detlev Riesner, has retired as Chairman of the Supervisory Board. He served on the board since 1996 and as chairman since 2003. Werner Brandt will become the new chairman. All other members of the supervisory board — Stéphane Bancel, Metin Colpan, Manfred Karobath, Lawrence Rosen, and Elizabeth Tallett — are being proposed for re-election to one-year terms at the annual general meeting. In addition, Elaine Mardis is being proposed for election as a new member. Mardis is co-director of the Genome Institute at Washington University in St. Louis. She is the Robert E. and Louise F. Dunn Distinguished Professor of Medicine, and also is a professor in the department of genetics at Wash U.

DNA Electronics has appointed Steve Allen to the position of COO. Prior to joining DNA Electronics, Allen was managing director of LGC Forensics. He has also served as managing director for the consulting company i2r Limited and held various positions at PerkinElmer. In addition, Allen was formerly a board member and advisor to Solexa, before Illumina bought it.

The Broad Institute has appointed two new members to its senior leadership team, including Samantha Singer as chief operating officer and Clare Midgley as chief communications officer.

Singer formerly was VP of corporate strategy and chief of staff for the CEO at Biogen Idec. As COO at the Broad she will oversee the institute's human resources, finance, facilities, and IT teams, as well as the office of strategic alliances and partnering.

Midgley is a communications strategy consultant who formerly was VP of global corporate affairs at Millennium Pharmaceuticals.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.